Indamax (Indapamide)

Indapamide blocks the sodium‑chloride transporter in the distal convoluted tubule of the kidney, preventing reabsorption of these ions. This leads to increased excretion of sodium, chloride, and water, lowering blood volume. Additionally, it causes direct relaxation of peripheral arterioles, decreasing vascular resistance and blood pressure.

The exact dose of Indamax is determined by the prescribing clinician based on the patient’s condition, age, kidney function, and response to therapy. Physicians typically start with a low dose and adjust as needed, following current clinical guidelines for hypertension or heart‑failure‑related edema.

Safety data for indapamide in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Indamax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Indapamide belongs to the thiazide‑like class, offering a longer duration of action and a more favorable metabolic profile than many traditional thiazide diuretics. It provides effective blood‑pressure control with a lower incidence of potassium loss, making it a preferred option for patients who require sustained antihypertensive therapy.

Indamax tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Indamax is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and whether to take it in the morning or evening to minimize nocturnal diuresis.

Serious risks include severe dehydration, significant electrolyte disturbances such as hyponatremia or hypokalemia, acute gout attacks, and rare allergic reactions like angioedema. Patients should be monitored for signs of these conditions, especially during the initial weeks of therapy.

Indamax is contraindicated in patients with anuria, severe renal impairment, or known hypersensitivity to indapamide or other sulfonamide‑derived drugs. Caution is also advised for individuals with gout, uncontrolled diabetes, or those taking interacting medications such as lithium or potassium‑sparing diuretics.